Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05848492
Status:
COMPLETED
Last Update Posted:
2023-05-08
First Post:
2023-04-27
Brief Title:
Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection
Sponsor:
Services Institute of Medical Sciences Pakistan
Organization:
Services Institute of Medical Sciences Pakistan
Study Overview
Official Title:
Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Invasive fungal infection is detecting candida species in blood cerebrospinal fluid or urine Clinical signs of invasive candidiasis may include lethargy temperature instability feeding intolerance apnea hypotension respiratory distress abdominal distension and thrombocytopenia Fungal infection has been associated with an increased risk of retinopathy of prematurity and chronic lung disease Preterm and low birth weight infants have an immature immune system that predisposes them to infections with bacteria viruses and fungi These infants usually require prolonged admission in the neonatal unit and there is often a need for the administration of broad-spectrum antibiotics which predisposes them to colonization with fungi that may invade to cause systemic disease8 Other risk factors for the development of invasive fungal infection include endotracheal intubation abdominal surgery the presence of a central venous catheter administration of H2 antagonists and steroids Infection with Candida species is the third most common cause of bloodstream infection in premature infants Mortality in preterm infants due to invasive candidiasis is around 20 and can be as high as 50 in infants weighing 1500g at birth Invasive candidiasis is the second most common infectious cause of death in extremely preterm infants The present study was conducted to determine the incidence of invasive candidiasis among preterm and very low birth weight infants in our neonatal unit and to evaluate the efficacy of prophylactic fluconazole in preventing invasive fungal infection Based on the results of the present study institutional guidelines may be designed in our neonatal unit relating to antifungal prophylaxis in preterm and very low birth weight infants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None